HCV NS3 Protease Inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20100099695A1
SERIAL NO

12447342

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MSD ITALIA S R L00189 ROME

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Butcher, John W Telford, US 18 214
Di, Francesco Maria Emilia Rome, IT 49 489
Ferrara, Marco Rome, IT 59 498
Gilbert, Kevin F Barto, US 11 199
Harper, Steven Rome, IT 21 382
Holloway, M Katharine Lansdale, US 21 356
Liverton, Nigel J Harleysville, US 51 720
McCauley, John A Maple Glen, US 67 584
McIntyre, Charles A Lansdale, US 2 35
Petrocchi, Alessia Rome, IT 40 445
Pompei, Marco Rome, IT 6 114
Romano, Joseph J Rome, IT 24 157
Rudd, Michael T Collegeville, US 40 281
Summa, Vincenzo Rome, IT 41 480

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation